Trends in radiation therapy administration at a pediatric cancer center in South India
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - 2025
Project Lead
Sakshi Garg
Authors
Sakshi Garg, Sandeep Muzumder, Hadrian Noel Alexander F, Avinash H. Udayashankara, Nirmala Srikantia, John Michael Raj
Project Status
completed
Project Type
Retrospective Cohort Study